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Introduction
High throughput in modern drug quality control requires assay of as many analytes as possible, in the shortest time, in a single analysis. When targeting structurally related compounds a single separation mechanism is usually considered using common selectivity enhancement techniques. When the compounds in a pharmaceutical combination exhibit a variety of structural characteristics (i.e., analytes containing opposite permanent charges or functional groups forming oppositely charged moieties upon dissociation), their separation is likely to be more complicated. The range of separation mechanisms can be extended by addition of buffers, ion-pairing agents or ionic liquids [1, 2] . If the compounds are present in very different amounts, selective isolation may be employed. Injectable solutions used for the symptomatic treatment of intense pain accompanied by smooth muscle spasms are often based on combinations of metamizole sodium (MTZ), fenpiverine bromide (FPB) and pitofenone hydrochloride (PTF), which produce synergistic rapid analgesic and spasmolytic action.
Due to its extensive and long term use, numerous methods have been reported for analysis of MTZ alone or in combination with other drugs in pharmaceutical formulations. These techniques include flow injection spectrophotometry [3] , capillary electrophoresis (CE) [4] , UV spectrophotometry [5] [6] [7] [8] , chemiluminescence [9] and liquid chromatography [10] [11] [12] . However, little literature was found on the simultaneous determination of MTZ, FPB and PTF. Ratio-spectra zero-crossing 1 st order derivative spectrophotometry [8, 13] was applied to determine the three drugs in injectable solutions. Liquidliquid extraction into chloroform followed by UV-Vis spectrometric determination [14] was used to assay only FPB in a tablet also containing MTZ and PTF. Thin layer chromatography (TLC) with direct densitometric detection was used to assay MTZ, PTF and FPB among other pharmaceuticals like codeine and etenzamide in sugarcoated tablets [15] . Fluorescent silica gel plates were eluted with benzene -methanol -diethylamine (3:3:1) and detection at 254 nm. No liquid chromatographic methods for simultaneous determination of MTZ, FPB and PTF were found in the literature.
Injectable solutions used in treatment of intense pain are based on combinations of active ingredients such as metamizole sodium (MTZ), pitofenone hydrochloride (PTF) and fenpiverine bromide (FPB). The simultaneous chromatographic assay of such combinations poses difficulties due to their structural variety, highly polar character, and wide concentration ranges (500 mg mL -1 for MTZ, 2 mg mL -1 for PTF and 0.02 mg mL -1 for FPB). Fast hydrolysis of MTZ on aqueous dilution causes additional problems due to impurity (MTC) formation. Sodium hexane sulphonate (10 mM) was used as ion pairing agent for PTF, FPB and MTC in a mobile phase consisting of 48/52 (v/v) methanol and aqueous 0.2% triethylamine at pH=3. The ionic liquid 1-butyl-1-methyl-pyrrolidinium tetrafluoroborate (10 mM) was used as mobile phase additive to preserve the MTZ peak symmetry. The minor active ingredient FPB was selectively extracted into 1-octanol by ion pair formation with picric acid. A 20 µL aliquot of the organic layer was directly injected into the column.
The aim of the present work was to develop and validate a selective and sensitive LC method for the simultaneous determination of the three active pharmaceutical ingredients (MTZ, FPB and PTF) in a commercially available injectable solution. As simple aqueous dilution leads to rapid formation of a metamizolerelated impurity, 4-methylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one (denoted MTC), this was added as a target analyte.
Sodium hexane sulphonate (10 mM) was used as ion pairing agent to separate PTF, FPB and MTC. The ionic liquid 1-butyl-1-methyl-pyrrolidinium tetrafluoroborate (10 mM) was added to the mobile phase to control retention and to preserve the first-eluting MTZ peak symmetry. Assay of MTZ, MTC and PTF was achieved on dilutions in methanol made directly from the injectable solution. As FPB is present at 1/25,000 of the MTZ concentration, its preliminary isolation in 1-octanol by liquid-liquid extraction of FPB-picric acid ion pairs was performed. An aliquot from the organic layer was directly injected onto the chromatographic column (without solvent removal and re-dissolution) operated under the same conditions as for MTZ, MTC and PTF. The method was successfully validated and applied to a commercially available injectable solution.
Experimental procedure

Reagents
HPLC grade methanol and 1-octanol, and picric acid proanalysis grade from Sigma-Aldrich (Steinheim, Germany) were used. Phosphoric acid, boric acid, acetic acid and sodium hydroxide were pro-analysis grade from Merck (Darmstadt, Germany), while triethylamine and 1-butyl-1-methyl-pyrrolidinium tetrafluoroborate, also proanalysis grade were from Fluka (Buchs, Switzerland). The ion pair agent was sodium hexane sulphonate, chromatography grade, obtained from Merck. Water for chromatography was produced by a TKA Lab HP 6UV/UF instrument. Reference standards of metamizole sodium monohydrate (sodium [(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-N-dimethyl amino] methane sulphonate monohydrate) and metamizole impurity C (4-methylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one) were obtained from LGC (Luckenwalde, Germany), while fenpiverine bromide (1-(4-amino-4-oxo-3,3-diphenylbutyl)-1-methylpiperidinium bromide) and pitofenone hydrochloride (methyl 2-{4-[2-(1-piperidinyl) ethoxy]benzoyl}benzoate hydrochloride) were obtained from Microsin (Bucharest, Romania). Britton-Robinson buffer of pH 10.4 was prepared by adding 0.2 M NaOH solution to an equimolar mixture (0.04 M) of boric, acetic and phosphoric acids.
Equipment
Experiments were performed using an Agilent 1100 series LC system (Agilent, Waldbronn, Germany) containing degasser (G1379A), binary pump (G1312A), autosampler (G1313A), column thermostat (G1316A), and diode array detector (G1315B) modules. Data acquisition and analysis were performed with Agilent Chemstation software, version B.03.02.
Chromatographic method
Chromatographic separation was carried out on a Luna C8(2) 150×4.6 mm ×5 µm column from Phenomenex, thermostated at 25°C. The isocratic mobile phase, pumped at 1.0 mL min -1 , consisted of (a) aqueous 10 mM 1-butyl-1-methyl-pyrrolidinium tetrafluoroborate, 10 mM sodium hexane sulphonate, 0.2% triethylamine adjusted to pH 3 with phosphoric acid, and (b) methanol in the ratio 52 : 48. The injection volume was 1 µL for the MTZ, MTC and PTF assay and 20 µL for FPB. UV detection was at 290 nm for MTZ, MTC and PTF and at 200 nm for FPB.
Development and optimization required several retention studies using different mobile phases. The effects of ionic liquid concentration (1-butyl-1-methyl-pyrrolidinium tetrafluoroborate) and ionpairing agent (hexyl sulphonate anion) on the analyte retention and peak shape were studied over the range 0 -15 mM. Volumes of 5, 10, 20, 50 and 100 µL of FPB solutions in 1-octanol were injected to examine the influence of injection volume on retention, peak shape and efficiency. The FPB concentrations were adjusted to keep the amount of analyte constant (100 ng). When samples in 1-octanol were injected the method included a column wash necessary for octanol plug elimination. This consisted of a 2 mL min -1 flow of methanol for 4 min followed by 3.5 min for re-equilibration at the initial composition and flow rate. When using 1-octanol as sample diluent, the autosampler draw speed was 100 µL min -1 to compensate for the solvent viscosity and to preserve injection reproducibility and accuracy.
During method development, a HILIC separation was also considered. A Luna HILIC column, 150×4.6 mm i.d. ×3 µm was operated isocratically at 25 o C and a flow rate of 1 mL min -1 , having as mobile phase a mixture of 9:1 acetonitrile / aqueous 50 mM ammonium formate adjusted to pH = 5.8 with formic acid.
Sample preparation
For MTZ and PTF at 500 mg mL -1 and 2 mg mL -1 respectively, sample preparation is based on dilution with methanol, as methanol dilution stabilizes MTZ towards hydrolysis to MTC. For PTF and MTC assay, a 1:25 (v/v) dilution of the injectable solution in methanol was performed (equivalent to 20 mg mL -1 metamizole sodium and 0.08 mg mL -1 pitofenone hydrochloride). For MTZ assay a 1:500 dilution (v/v) in methanol was performed, yielding 1000 µg mL -1 . Dilutions were prepared immediately before injection to avoid further degradation of the parent compound. The standard solution in methanol contained 1 mg mL -1 MTZ, 0.08 mg mL -1 PTF, and 0.7 mg mL -1 MTC (equivalent to the impurity threshold of 3.5% of MTZ, the maximum acceptable).
For FPB, present at a much lower concentration (0.02 mg mL -1 ), a different approach to sample preparation was necessary. A selective liquid-liquid extraction was employed to isolate FPB and eliminate most of the MTZ. Thus, 0.5 mL of injectable solution was mixed with 0.25 mL Britton-Robinson buffer at pH 10.4 and 0.25 mL of 30 mM aqueous picric acid. The mixture was vortexed for 10 seconds. One milliliter of 1-octanol was added; the test tube was then capped and vortexed at the highest speed for 10 min. After phase separation, an aliquot of the upper organic layer was transferred to an injection vial. The standard used for the FPB assay was obtained by applying this sample preparation procedure to a standard aqueous solution containing 0.02 mg mL -1 FPB, 500 mg mL -1 MTZ and 2 mg mL -1 PTF. It is noteworthy that the absence of the other two active substances from the mixture leads to increased FPB extraction yields.
Results and discussion
General method considerations
All target analytes ( Fig. 1) 
Ion-pair separation mechanism
An ion-pairing mechanism using an alkyl sulphonate anion (10 mM) in the mobile phase at pH 3 was chosen to increase retention and provide good separation between MTC, FPB and PTF. Although MTZ contains an amino group, it does not ion-pair with the hexyl sulphonate anion because its own sulphonate group induces electrostatic repulsion. Moreover, salting-out of MTZ by the ion-pairing agent causes a retention decrease. The use of ionic liquids as mobile phase additives was recently introduced in RP-LC [17, 18] . They eliminate the electrostatic interaction between residual silanols on the stationary phase and protonated analytes. Ionic liquid cation mono or bilayers adsorb on the stationary phase leading to increased peak symmetry but also to reduced retention [19] .
The possibility of ion pair formation between the MTZ sulphonate and the 1-butyl-1-methyl-pyrrolidinium cation was first assessed. Mobile phases containing 0, 5, 10 and 15 mM 1-butyl-1-methyl-pyrrolidinium tetrafluoroborate (ionic liquid, IL) were prepared without sodium hexane sulphonate (ion pairing agent, IPA). Ion pair formation was excluded, as MTZ retention did not increase with increasing mobile phase IL concentration. The MTZ peak symmetry improves from 0.7 to 0.9 with increasing IL concentration. When sodium hexane sulphonate and IL were simultaneously added to the mobile phase (10 mM each) decreased MTC, FPB and PTF retention was observed, while MTZ retention slightly increased. The reduction of MTC, FPB and PTF retention is explained by a shift in the ion pair formation equilibrium by the 1-butyl-1-methyl-pyrrolidinium cation. The slight increase in MTZ retention may be explained by formation of a bi-layer of 1-butyl-1-methyl-pyrrolidinium cations on the surface of the stationary phase. Positively charged centers on the stationary phase surface may interact with the MTZ sulphonate, leading to increased retention.
In the presence of the ionic liquid, varying the mobile phase sodium hexane sulphonate concentration affects the retention factor k (Fig. 3) .
The right side of the MTZ peak is slightly distorted when only the ion pairing agent is added to the mobile phase. Simultaneous addition of the ionic liquid eliminates this distortion (Supplemental Information, Supplementary Fig. A) .
A reduction of methanol by 5% in the mobile phase increases the MTZ retention by 6% and PTF retention by 90%. This reduction is not sufficient to increase MTZ retention and improve throughput.
Optimization of FPB extraction into 1-octanol
Quantitation of FPB in the injectable solution is difficult due to the large excess of MTZ (concentration ratio 1:25,000). Direct loading of the undiluted sample decreases the column performance after a limited number of injections. Increasing sensitivity by changing the detection wavelength from 290 nm to 200 nm increases interference risks from unknown MTZ T. Galaon et al.
degradation products (Supplemental Information, Supplementary Fig. B ). Both issues suggest preliminary separation of FPB from MTZ. The demonstrated poor ion pairing ability of MTZ with voluminous anions or cations and FPB's ready ion pairing with alkyl sulphonates suggested a liquidliquid extraction (LLE) of ion paired species of FPB into an apolar organic solvent.
The ability of FPB to form ion pairs with picric acid has been noted [14] . Their amino groups cause PTF and MTC to behave similarly. Alkaline conditions produce dissociation of the phenol function on the ion pairing agent. For additional simplification it would be preferable to inject aliquots of the organic layer directly onto the chromatographic column, without removal of the extractant. This requires greater retention of the organic solvent than the analytes [20, 21] . The simultaneous use of 1-octanol as extractant and injection diluent has been already reported [22, 23] . Thus, picric acid as ion pairing agent and 1-octanol as extractant were used. The chromatographic method remained the same as for the assay of MTZ, MTC and PTF. Changes consist in performing 20 µL injections and shifting detection from 290 to 200 nm.
Separate extraction of the individual analytes from alkalinized aqueous phase (chapter 2.4) into 1-octanol gave quantitative removal of FPB and MTC, while extraction yields for PTF and MTZ were 88% and 0.4%, respectively. When extracted together in the amounts present in the pharmaceutical, FPB and PTF extraction yields decreased to 48% and 78%, respectively. Yields of MTC and MTZ remained unchanged.
Omitting the ion pairing agent reduces extraction yields by a factor of 5. Increasing the aqueous phase picric acid concentration increases yields, but increasing its concentration above 30 mM is not justified by the gain. The picric acid elutes closely after MTC but does not interfere with the FPB peak.
1-octanol as sample diluent
The general rule for a successful large volume injection in LC is that the sample diluent should be compatible with and weaker than the mobile phase. If these criteria are not met, band broadening, peak asymmetry and peak distortion occur [24] . Recent studies examined the possibility of injecting diluents stronger than [25, 26] or even immiscible with [21-23] the mobile phase. These alternatives are based on the stronger interaction of the diluent than analytes with the stationary phase. The diluent saturates a region of the stationary phase (proportional to the injected volume) at the column head. The analytes diffuse out of the solvent plug into the mobile phase and distribute within the remaining volume of stationary phase. Consequently, analyte retention is progressively reduced with increasing injected volume. 1-octanol (logD ow =2.58 at pH=3 [16] ) is more hydrophobic than MTZ, MTC, FPB and PTF. Thus its retention on a reversed phase column should be higher, meeting the principal requirement for a successful large volume injection. To test this possibility, 5, 10, 20, 50 and 100 µL Use of an immiscible diluent in ionic liquid / ion pair LC for the assay of an injectable analgesic of FPB solutions in 1-octanol were injected, keeping the amount of FPB loaded constant (100 ng). The FPB peak efficiency (N), retention factor (k) and peak symmetry (As) given by the Agilent software are plotted against the injected volume (Fig. 4) . The hypothesized linear retention reduction on increasing injected volume was confirmed. Efficiency also decreases linearly by around 18%. Peak symmetry is unaffected. An injection volume of 20 µL is high enough to provide the required sensitivity and to avoid overlap of the FPB and residual picric acid peaks. The 1-octanol plug is removed by flushing the column with methanol. Combined with column equilibration, this doubled the run time (16 minutes between injections vs. 8). However, this is less than the time required by solvent evaporation followed by re-dissolution, and sample manipulation errors are avoided.
Method validation for MTZ, PTF and MTC
MTZ, MTC and PTF were asayed following simple methanol dilutions of the injectable solution (section 2.4). Method validation followed updated ICH guidelines [27] . Linearity was studied over 80 -120% of the nominal concentrations. For MTC the linearity range was from the LOQ to 140% of the maximum allowed in the pharmaceutical. The method performance characteristics are summarized in Table 1 . Although ICH guidelines do not require determination of LOQ, Table 1 contains this for MTZ and PTF. For MTC, a related impurity, LOQ is essential. A 10:1 S/N ratio corresponds to a 10 µg mL -1 MTC, equivalent to 0.05% impurity C in the MTZ.
For all three analytes good correlation coefficients were obtained. RSD% for intra-and inter-day repeatability (n = 6) was within 1%, with maximum bias 1%. For MTZ and PTF accuracy was evaluated at 90, 100 and 110% of nominal concentrations; for MTC at LOQ, 100%, and 140% of the maximum acceptable concentration. MTZ and PTF gave very good recoveries (max 1.6% bias) and low RSD% values (max 1.4%). Recoveries for MTC were between 99.9 and 100.6% for the high concentration levels and 107% at the LOQ.
Standard and test sample solution stability was assessed at room temperature (25°C) and in the cold (light protected at 6°C). Due to rapid hydrolysis of MTZ to MTC in aqueous media or at increased temperature, the purity test solution for MTC assay should be injected immediately after dilution in methanol (containing 4% water). After only 30 minutes, a 5% MTC content increase was observed. PTF is stable up to 2 days at 25°C and up to 4 days at 6°C. MTZ is stable for 2 hours at room temperature and 6 hours at 6°C. After these periods peak area decreased more than 2%.
Method robustness was also evaluated. Parameters were deliberately modified over small ranges to observe changes in selectivity. Modification of mobile phase composition (±2%), column temperature (±2°C), column batch number, as well as ionic liquid and ion-pairing agent concentrations (±50%) gave no significant change in resolution. 
Method validation for FPB
The linear range for FPB was investigated over 80 -120% of its nominal concentration (16 -24 µg mL -1 ). Selectivity (peak purity evaluation and placebo interference check), precision (6 samples at 1 concentration level over different days and analysts), accuracy (3 concentration levels with at least 3 samples) and sample stability are listed in Table 2 .
Selectivity for FPB was demonstrated by peak purity tests. 1-Octanol as well as the octanol extracts resulting from applying the liquid-liquid extraction to: (a) a water blank, (b) water spiked with the nominal amounts of MTZ and PTF, (c) standard, and (d) sample were injected. Illustration of the method's selectivity is given in Fig. 5 . Blank samples showed no interferences with the FPB peak and in chromatograms obtained after injection of the standard FPB solution no interfering peaks were observed. Resolution between picric acid/FPB and FPB/PTF peak pairs in the standard FPB solution chromatogram was 5.3 and 3.9, respectively. RSD% for intra-and interday repeatability (n = 6) was below 2% with bias 0.9 -1.6%. Accuracy was evaluated at 90, 100 and 110% of FPB nominal concentration and provided recoveries between 100.9 -102.6% and RSD% values between 0.4 -1.8%. Sample stability was assessed on extracted samples of FPB both at room temperature (25°C) and cold conditions (light protected at 6°C). Samples were stable (maximum 2% peak area decrease) for 1 day at room temperature and 2 days at 6°C.
Conclusions
A rapid, sensitive, selective and accurate ionic liquid/ ion-pair RP-LC method was developed for the simultaneous assay of MTZ, FPB, PTF and MTC in an injectable analgesic solution. Ion pairing based liquidliquid extraction into 1-octanol was used to isolate FPB from MTZ, increasing sensitivity and selectivity. FPB was extracted into 1-octanol as an ion pair with picric acid and the organic layer was directly injected onto the column. Direct injection caused no negative effects on peak shapes or efficiency and avoids tedious and error-prone sampling, solvent evaporation and residue re-dissolution. The liquid-liquid extraction procedure required 16 minutes and provided good accuracy.
The method was validated and applied to the assay of all four compounds in an injectable pharmaceutical on the Romanian market. This demonstrates the usefulness of large volume injection of immiscible diluents in RP-LC applications. 1-octanol, after addition of the ion pairing agent (picric acid) to the aqueous phase; c) extraction of MTZ, MTC and PTF into 1-octanol using picric acid as ion pairing agent; d) extraction of the sample (analgesic injectable solution) as described in section 2.4.
